I. Chung

发表

Adenoviral vectors and hematopoietic cells.

A. Deisseroth, S. Fu, F. García Sánchez, 1997, Blood.

No role of protected region b of human cytochrome P4501A2 gene (CYP1A2) as an AP-1 response element

K. Jung, I. Chung, 2002, Archives of pharmacal research.

Gene Therapy for Oral Cancer

I. Chung, 2007 .

The Basis of Different Sensitivities of Ovarian Cancer Cells to the Recombinant Adenoviral Vector System Containing a Tumor-Specific L-plastin Promoter and E. coli Cytosine Deaminase Gene as a Transcription Unit

I. Chung, 2009 .

Cytotoxic effect of a replication-incompetent adenoviral vector with cytosine deaminase gene driven by L-plastin promoter in hepatocellular carcinoma cells

Changmin Kim, Sunja Kim, K. Jung, 2007, Archives of pharmacal research.

Recombinant adenoviral vector containing tumor-specific l-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test

A. Deisseroth, I. Chung, 2004, Archives of pharmacal research.

Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells

R. Crystal, A. Deisseroth, P. Schwartz, 1999, Cancer Gene Therapy.

Regulation of the constitutive expression of the human CYP1A2 gene: cis elements and their interactions with proteins.

E. Bresnick, I. Chung, 1995, Molecular pharmacology.

Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo

A. Eastman, Ruth Thompson, N. Khan, 2013, BMC Cancer.

Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and Antimetabolites

A. Eastman, D. Parry, R. Montano, 2011, Molecular Cancer Therapeutics.

Preclinical Development Preclinical Development of the Novel Chk 1 Inhibitor SCH 900776 in Combination with DNA-Damaging Agents and Antimetabolites

A. Eastman, D. Parry, R. Montano, 2012 .

Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene.

E. Bresnick, I. Chung, Edward Bresnick, 1997, Archives of biochemistry and biophysics.

Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I

Robert F. Harvey, P. Fischer, J. Hirst, 2020, eLife.

Results of retroviral and adenoviral approaches to cancer gene therapy

S. Heimfeld, R. Crystal, A. Deisseroth, 1998, Stem cells.